Results 131 to 140 of about 76,948 (211)

Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer. [PDF]

Pharmaceuticals (Basel)
Ji Y, Huth F, Wang C, Schiller H, Combes FP, Crown J, Fasching PA, Zarate JP, Untch M.   +8 more
europepmc   +1 more source

Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma. [PDF]

Biomedicines
Sanz-Solas A, Pérez-Gómez N, Labrador J, Cuevas B, Cuevas MV, Díaz-Gálvez FJ, Hermida G, Álvarez-Nuño R, Benzo G, Alonso-Madrigal C, González-Oter M, García-Sancha N, Vinuesa R, Rodríguez-Lopez A, Novalbos J, Busto N, Alcaraz R, Abad-Santos F, Saiz-Rodríguez M.   +18 more
europepmc   +1 more source

Mechanistic insights into atorvastatin-induced hepatotoxicity: molecular pathways, clinical relevance, and strategies for safer personalized therapy. [PDF]

Clin Exp Med
Abdel-Rasol MA, El-Sayed WM.
europepmc   +1 more source

CYP3A4 wt Allele [PDF]

, 2020
openaire   +1 more source

Mechanistic insights into voriconazole-exacerbated selpercatinib-induced thrombocytopenia: a pharmacokinetic interaction case report. [PDF]

Front Oncol
Tang H, Zhou Z, Zhang Y, Chen W, Meng J, Li G.   +5 more
europepmc   +1 more source

Lipid Dependence of CYP3A4 Activity in Nanodiscs. [PDF]

Biology (Basel)
Denisov IG, Grinkova YV, Sligar SG.
europepmc   +1 more source

Coenzyme Q10 protects against atorvastatin-induced hepatotoxicity via attenuation of oxidative stress and functional modulation of CYP3A1. [PDF]

BMC Pharmacol Toxicol
Abdel-Rasol MA, Anwar MS, Taha HA, El-Sayed WM, AbdelRaouf K.   +4 more
europepmc   +1 more source

Simulation of Imatinib Pharmacokinetics in pregnant women with chronic myeloid leukemia in the third trimester. [PDF]

Eur J Clin Pharmacol
Mian P, Lok CAR, Dontje AEWK, Prins JR, Oude Munnink TH, Nieuwenhuizen L, Gordijn SJ, Touw DJ, Malik P.   +8 more
europepmc   +1 more source

Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers [PDF]

, 2018
et al,, Uy, Geoffrey L
core   +1 more source

Evaluation of Drug-Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants. [PDF]

Clin Transl Sci
Luckey A, Larson KB, Rayad N, Heep M, Delhomme S, Kornmann G, Mueller JP, O'Donnell JP, O'Brien S, Fuhr R, Gillon JY.   +10 more
europepmc   +1 more source